BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1714000)

  • 1. Electrophysiologic effects of verapamil metabolites in the isolated heart.
    Johnson KE; Balderston SM; Pieper JA; Mann DE; Reiter MJ
    J Cardiovasc Pharmacol; 1991 May; 17(5):830-7. PubMed ID: 1714000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic evaluation of cardiovascular agents in the isolated intact rabbit heart.
    Balderston SM; Johnson KE; Reiter MJ
    J Pharmacol Methods; 1991 May; 25(3):205-13. PubMed ID: 1905367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels and urinary excretion of verapamil, norverapamil, N-dealkylverapamil (D617), N-dealkylnorverapamil (D620) following oral administration of a slow-release preparation.
    Barbieri E; Padrini R; Piovan D; Toffoli M; Cargnelli G; Trevi G; Ferrari M
    Int J Clin Pharmacol Res; 1985; 5(2):99-107. PubMed ID: 4018947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrioventricular node reentry: intravenous verapamil as a method of defining multiple electrophysiologic types.
    Hamer A; Peter T; Mandel W
    Am Heart J; 1983 Apr; 105(4):629-42. PubMed ID: 6837417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of volatile anesthetics on atrial and AV nodal electrophysiological properties in guinea pig isolated perfused heart.
    Raatikainen MJ; Trankina MF; Morey TE; Dennis DM
    Anesthesiology; 1998 Aug; 89(2):434-42. PubMed ID: 9710402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit.
    Khori V; Alizadeh AM; Moheimani HR; Zahedi M; Aminolsharieh Najafi S; Shakiba D; Nayebpour M
    Fundam Clin Pharmacol; 2015 Feb; 29(1):41-53. PubMed ID: 24990322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of verapamil-induced conduction block in anomalous atrioventricular bypass tracts.
    Tai DY; Chang MS; Svinarich JT; Chiang BN; Sung RJ
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):311-7. PubMed ID: 3968316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the site of stimulation on atrioventricular nodal refractory periods and the effect of verapamil.
    Iinuma H; Dreifus LS; Price R; Michelson EL
    Am J Cardiol; 1986 May; 57(13):1167-74. PubMed ID: 3706171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the direct effects of nifedipine and verapamil on the electrical activity of the sinoatrial and atrioventricular nodes of the rabbit heart.
    Ning W; Wit AL
    Am Heart J; 1983 Aug; 106(2):345-55. PubMed ID: 6869216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of dextro- and levo-verapamil on sinus node and AV node function in humans.
    Echizen H; Manz M; Eichelbaum M
    J Cardiovasc Pharmacol; 1988; 12(5):543-6. PubMed ID: 2468053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metabolites on protein binding of verapamil enantiomers.
    Johnson JA; Akers WS
    Br J Clin Pharmacol; 1995 May; 39(5):536-8. PubMed ID: 7669491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic evaluation of intravenous verapamil in man.
    Rizzon P; Di Biase M; Calabrese P; Brindicci G; Chiddo A
    Eur J Cardiol; 1977; 6(3):179-94. PubMed ID: 338305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction.
    Prystowsky EN
    J Clin Pharmacol; 1988 Jan; 28(1):6-21. PubMed ID: 2450898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prophylaxis of AV nodal re-entry tachycardia.
    Tonkin AM; Shorne L
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic study of patients with short P-R interval and normal QRS complex.
    Moro C; Cosío FG
    Eur J Cardiol; 1980 Feb; 11(2):81-90. PubMed ID: 7363927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction.
    Rinne C; Sharma AD; Klein GJ; Yee R; Szabo T
    Am Heart J; 1988 May; 115(5):1042-7. PubMed ID: 3364337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrophysiological effects of alpha-chloralose anesthesia in the intact dog: (1) alone and (2) in combination with verapamil.
    Schwartz JB; Herre JM
    Pacing Clin Electrophysiol; 1989 Feb; 12(2):283-93. PubMed ID: 2468138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of combined propranolol and verapamil for evaluation of surgical ablation of accessory atrioventricular connections in patients without structural heart disease.
    Milstein S; Dunnigan A; Buetikofer J; Benditt DG; Crosson J; Pineda E
    Am J Cardiol; 1990 Nov; 66(17):1216-21. PubMed ID: 2239726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of verapamil on the electrophysiology of the intact immature mammalian heart.
    Pickoff AS; Flinn CJ; Singh S; Gelband H
    J Cardiovasc Pharmacol; 1985; 7(1):125-30. PubMed ID: 2580132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
    Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.